rs121918510
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3PP5_Moderate
The NM_000141.5(FGFR2):c.962A>T(p.Asp321Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D321E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Publications
- Apert syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- Beare-Stevenson cutis gyrata syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Genomics England PanelApp
- Crouzon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, PanelApp Australia, Genomics England PanelApp, G2P
- Jackson-Weiss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- LADD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- bent bone dysplasia syndrome 1Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- familial scaphocephaly syndrome, McGillivray typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Saethre-Chotzen syndromeInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Antley-Bixler syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LADD syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | ENST00000358487.10 | c.962A>T | p.Asp321Val | missense_variant | Exon 8 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
| FGFR2 | ENST00000613048.4 | c.695A>T | p.Asp232Val | missense_variant | Exon 7 of 17 | 5 | ENSP00000484154.1 | |||
| FGFR2 | ENST00000478859.5 | c.278A>T | p.Asp93Val | missense_variant | Exon 7 of 17 | 1 | ENSP00000474011.1 | |||
| FGFR2 | ENST00000604236.5 | n.*9A>T | non_coding_transcript_exon_variant | Exon 7 of 17 | 1 | ENSP00000474109.1 | ||||
| FGFR2 | ENST00000604236.5 | n.*9A>T | 3_prime_UTR_variant | Exon 7 of 17 | 1 | ENSP00000474109.1 | ||||
| FGFR2 | ENST00000457416.7 | c.1087+1241A>T | intron_variant | Intron 8 of 17 | 1 | ENSP00000410294.2 | ||||
| FGFR2 | ENST00000369056.5 | c.1087+1241A>T | intron_variant | Intron 7 of 16 | 1 | ENSP00000358052.1 | ||||
| FGFR2 | ENST00000369058.7 | c.1087+1241A>T | intron_variant | Intron 8 of 16 | 1 | ENSP00000358054.3 | ||||
| FGFR2 | ENST00000369061.8 | c.749-2122A>T | intron_variant | Intron 5 of 14 | 1 | ENSP00000358057.4 | ||||
| FGFR2 | ENST00000369059.5 | c.742+1241A>T | intron_variant | Intron 6 of 15 | 5 | ENSP00000358055.1 | ||||
| FGFR2 | ENST00000360144.7 | c.820+1241A>T | intron_variant | Intron 7 of 16 | 2 | ENSP00000353262.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
FGFR2-related craniosynostosis Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 1060632). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR2 protein function. This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 321 of the FGFR2 protein (p.Asp321Val). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of FGFR2-related conditions (PMID: 29109840; Invitae). This variant disrupts the p.Asp321 amino acid residue in FGFR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7719333, 9531645, 9586546, 10394936). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at